This is a translation of the Swedish press release published 2022-09-12
Neola Medical AB (publ) will participate at ABG Sundal Colliers Investor Day in Stockholm the 13th of September and present the company. At 15.00 (3 pm) CEO Hanna Sjöström will present the company, upcoming milestones, and the coming rights issue. Following the presentation there will be a shorter Q&A moderated by an ABGSC-analyst.
“I look forward to presenting at ABG:s Investor Day. We have made great progress in the last six months with positive results from a clinical study and we have an exciting fall ahead with further milestones and a rights issue.”, says Hanna Sjöström, CEO at Neola Medical.
The presentation will be available at the following link from the 14th of September: https://cr.abgsc.com
Read the full translation of the Swedish press release here: Press communication